Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
AIM's Serum-Free Iterative Rabies Vaccine Receives Acceptance for Market Registration; Institutions Predict Significant Valuation Recovery Potential for the Company 2025-04-08 08:00
World Health Day Focus: Yeast Protein for Muscle Gain Unveiled through Scientific Clinical Trials 2025-04-07 16:41
ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases 2025-04-07 08:34
George Clinical Rebrands as Emerald Clinical Trials 2025-04-07 08:00
Telix Appoints Paul Schaffer as Chief Technology Officer 2025-04-07 07:09
Breakthrough Prize Foundation Announces Student Winner of 10th Annual Breakthrough Junior Challenge Science Video Competition 2025-04-06 06:30
BREAKTHROUGH PRIZE ANNOUNCES 2025 LAUREATES IN LIFE SCIENCES, FUNDAMENTAL PHYSICS, AND MATHEMATICS 2025-04-06 06:30
IRBM Expands Functional Genomics Platform to Strengthen Early Drug Discovery 2025-04-03 07:45
Change in Management: Exyte announces Katrien Verlinden as new President of its Global Business Unit Advanced Technology Facilities 2025-04-02 17:00
Revenue Soars 44%, Basecare Medical (2170.HK) Advances Toward Global Intelligent Manufacturing 2025-03-31 17:01
Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179's Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification 2025-03-30 19:10
Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients 2025-03-28 09:00
TraceLink Secures Top Honors with BSMA Supply Chain Excellence Award for Multienterprise Information Network Tower (MINT) Innovation 2025-03-28 03:49
Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D 2025-03-27 21:35
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2025 AACR Annual Meeting 2025-03-27 09:17
Turn Biotechnologies Acquires ARMMs Vesicular Technology to Increase Access to Tissue Targets for its Epigenetic Reprogramming Therapies 2025-03-26 21:00
ANNOUNCEMENT OF ANNUAL RESULTS FOR 2024 2025-03-26 19:08
Innovent Announces 2024 Annual Results and Business Updates 2025-03-26 19:02
Antengene to Present Results From Four Cutting Edge Preclinical Studies at AACR 2025 with Focuses Including AnTenGagerTM TCEs and Synthetic Lethality 2025-03-26 16:28
Gene Solutions Leads the Way in Cancer Early Detection with Asia's First Clinical Validated Multi-Cancer Blood Test 2025-03-26 13:00
1 23 24 25 26 27 264